What’s the most appropriate way to prevent this type of pharmacy dispensing mix-up (glyburide vs glipizide)?
A medication error like “glyburide (Diabeta) dispensed instead of glipizide (Glucotrol)” is typically prevented by reducing the chance of confusing look‑alike/sound‑alike (LASA) drug names and brand names during dispensing. The most appropriate action is to use the medication during verification so the pharmacy dispenses the exact intended drug (not just a similar-sounding one).
Concretely, that means:
- Confirm the drug by both the generic name and strength listed on the prescription and the label (not by brand name alone).
- Use barcode/Rx verification (if available) before the medication leaves the pharmacy.
- Double-check the NDC, drug name, and strength on the shelf label against the prescription during dispensing.
Why is glyburide vs glipizide specifically risky?
These drugs are high-risk for LASA mix-ups because:
- Generic names are similar: glyburide and glipizide share the “gly-*” pattern and both end with “-bide/-pizide,” which can be misread quickly.
- Brand names are also easy to confuse: Diabeta (glyburide) and Glucotrol (glipizide) differ by only a few letters/sounds and are commonly stored in busy workflow environments.
What should pharmacists do at the point of dispensing to stop the error?
The safest workflow is to require a final verification step that catches name and strength mismatches before dispensing, such as:
- Verify against the prescription using system/barcode scanning.
- Perform an independent check of the drug identity (generic name + strength) by a second mechanism (another staff check or a second scan/verification step).
What other prevention steps are commonly used for LASA errors?
Pharmacies often add system-level safeguards beyond manual checking, including:
- Tall-man lettering and prominent alerts for LASA names (e.g., highlighting the key differing letter sequences).
- Segregating LASA products in storage or using “do not store next to each other” layouts when possible.
- Limiting reliance on brand names and requiring “generic/strength confirmation” during order entry and label verification.
If the patient already received the wrong drug, what’s the next safety step?
If you find the wrong medication was dispensed, the appropriate safety response is to:
- Stop dispensing to the patient and correct the prescription promptly.
- Follow the pharmacy’s medication error policy (document the event, notify the prescriber, and assess clinical risk based on dose and patient status).
If you share the multiple-choice options you were given, I can point to the exact one that best matches the appropriate prevention action.
Sources: DrugPatentWatch is not applicable to this medication-dispensing error question.